BRISTOL MYERS SQUIBB CO Quarterly Goodwill in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Bristol Myers Squibb Co quarterly Goodwill history and growth rate from Q1 2010 to Q3 2024.
  • Bristol Myers Squibb Co Goodwill for the quarter ending September 30, 2024 was $21.8B, a 2.86% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $21.8B +$604M +2.86% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $21.7B +$569M +2.69% Jun 30, 2024 10-Q 2024-07-26
Q1 2024 $21.7B +$576M +2.72% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $21.2B +$20M +0.1% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $21.1B +$35M +0.17% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $21.2B +$717M +3.51% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $21.2B +$662M +3.23% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $21.1B +$647M +3.16% Dec 31, 2022 10-K 2024-02-13
Q3 2022 $21.1B +$593M +2.89% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $20.4B -$83M -0.4% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $20.5B -$24M -0.12% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $20.5B -$45M -0.22% Dec 31, 2021 10-K 2024-02-13
Q3 2021 $20.5B +$2M +0.01% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 $20.5B -$49M -0.24% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $20.5B -$1.93B -8.59% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $20.5B -$1.94B -8.63% Dec 31, 2020 10-K 2023-02-14
Q3 2020 $20.5B +$14B +215% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $20.6B +$14B +215% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $22.5B +$15.9B +244% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $22.5B +$16B +244% Dec 31, 2019 10-K 2021-02-10
Q3 2019 $6.51B -$173M -2.59% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $6.53B -$150M -2.25% Jun 30, 2019 10-Q 2019-07-25
Q1 2019 $6.54B -$327M -4.77% Mar 31, 2019 10-Q 2019-04-25
Q4 2018 $6.54B -$325M -4.74% Dec 31, 2018 10-K 2020-02-24
Q3 2018 $6.69B -$179M -2.61% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $6.68B -$178M -2.59% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $6.86B -$12M -0.18% Mar 31, 2018 10-Q 2018-04-26
Q4 2017 $6.86B -$12M -0.18% Dec 31, 2017 10-K 2019-02-25
Q3 2017 $6.87B -$10M -0.15% Sep 30, 2017 10-Q 2017-10-26
Q2 2017 $6.86B -$14M -0.2% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 $6.88B $0 0% Mar 31, 2017 10-Q 2017-04-27
Q4 2016 $6.88B -$6M -0.09% Dec 31, 2016 10-K 2018-02-13
Q3 2016 $6.88B -$77M -1.11% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $6.88B -$101M -1.45% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 $6.88B -$152M -2.16% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 $6.88B -$146M -2.08% Dec 31, 2015 10-K 2017-02-21
Q3 2015 $6.95B -$94M -1.33% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 $6.98B -$70M -0.99% Jun 30, 2015 10-Q 2015-07-23
Q1 2015 $7.03B -$19M -0.27% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $7.03B -$69M -0.97% Dec 31, 2014 10-K 2016-02-12
Q3 2014 $7.05B -$600M -7.85% Sep 30, 2014 10-Q 2014-10-24
Q2 2014 $7.05B -$600M -7.85% Jun 30, 2014 10-Q 2014-07-24
Q1 2014 $7.05B -$600M -7.85% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 $7.1B -$539M -7.06% Dec 31, 2013 10-K 2015-02-13
Q3 2013 $7.65B +$148M +1.97% Sep 30, 2013 10-Q 2013-10-23
Q2 2013 $7.65B +$847M +12.5% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 $7.65B +$847M +12.5% Mar 31, 2013 10-Q 2013-04-25
Q4 2012 $7.64B +$2.05B +36.7% Dec 31, 2012 10-K 2014-02-14
Q3 2012 $7.5B +$1.93B +34.8% Sep 30, 2012 10-Q 2012-10-24
Q2 2012 $6.8B +$1.57B +29.9% Jun 30, 2012 10-Q 2012-07-25
Q1 2012 $6.8B +$1.57B +29.9% Mar 31, 2012 10-Q 2012-04-26
Q4 2011 $5.59B +$353M +6.75% Dec 31, 2011 10-K 2014-02-14
Q3 2011 $5.56B +$346M +6.63% Sep 30, 2011 10-Q 2011-10-27
Q2 2011 $5.23B +$15M +0.29% Jun 30, 2011 10-Q 2011-07-28
Q1 2011 $5.23B +$15M +0.29% Mar 31, 2011 10-Q 2011-04-28
Q4 2010 $5.23B Dec 31, 2010 10-K 2012-02-17
Q3 2010 $5.22B Sep 30, 2010 10-Q 2010-10-26
Q2 2010 $5.22B Jun 30, 2010 10-Q 2010-07-22
Q1 2010 $5.22B Mar 31, 2010 10-Q 2010-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.